TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Evomed AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,134
|
1,982
|
2,178 |
| Financial expenses |
0
|
2
|
8 |
| Earnings before taxes |
116
|
134
|
-70 |
| EBITDA |
140
|
161
|
-34 |
| Total assets |
505
|
535
|
472 |
| Current assets |
456
|
458
|
367 |
| Current liabilities |
144
|
115
|
161 |
| Equity capital |
361
|
420
|
311 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
71.5%
|
78.5%
|
65.9% |
| Turnover per employee |
2,134
|
1,982
|
726 |
| Profit as a percentage of turnover |
5.4%
|
6.8%
|
-3.2% |
| Return on assets (ROA) |
23.0%
|
25.4%
|
-13.1% |
| Current ratio |
316.7%
|
398.3%
|
228.0% |
| Return on equity (ROE) |
32.1%
|
31.9%
|
-22.5% |
| Change turnover |
152
|
-196
|
-464 |
| Change turnover % |
8%
|
-9%
|
-18% |
| Chg. No. of employees |
0
|
-2
|
0 |
| Chg. No. of employees % |
0%
|
-67%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.